Your Health, We Care

Home > Photo Wall > Honor and qualification

DOPTELET Production Approval

Release date: 2024-07-09 16:50:45     Recommended: 159

04L0959_23 阿伐曲波帕 批文_00.jpg

DOPTELET is also suitable for the treatment of thrombocytopenia in adult patients with chronic liver disease who plan to undergo surgery, and for the treatment of chronic immune thrombocytopenia in adult patients with insufficient response to previous treatments.

Company News

Research News

Drug news